Multiple sclerosis: a battle between destruction and repair
- PMID: 17101032
- DOI: 10.1111/j.1471-4159.2006.04232.x
Multiple sclerosis: a battle between destruction and repair
Abstract
Multiple sclerosis (MS) is a chronic neurodegenerative disease of the CNS in which an unrelenting attack from the innate and adaptive arms of the immune system results in extensive demyelination, loss of oligodendrocytes and axonal degeneration. This review summarizes advances in the understanding of the cellular and molecular pathways involved in neurodegeneration following autoimmune-mediated inflammation in the CNS. The mechanisms underlying myelin and axonal destruction and the equally important interaction between degenerative and repair mechanisms are discussed. Recent studies have revealed that the failure of CNS regeneration may be in part a result of the presence of myelin-associated growth inhibitory molecules in MS lesions. Successful therapeutic intervention in MS is likely to require suppression of the inflammatory response, in concert with blockade of growth inhibitory molecules and possibly the mobilization or transplantation of stem cells for regeneration.
Similar articles
-
[Regenerative capacity in multiple sclerosis].Bull Acad Natl Med. 2008 Mar;192(3):495-504; discussion 505-6. Bull Acad Natl Med. 2008. PMID: 18819695 Review. French.
-
The pathology of MS: new insights and potential clinical applications.Neurologist. 2007 Mar;13(2):45-56. doi: 10.1097/01.nrl.0000253065.31662.37. Neurologist. 2007. PMID: 17351524 Review.
-
Neurodegeneration in autoimmune CNS inflammation.Exp Neurol. 2010 Sep;225(1):9-17. doi: 10.1016/j.expneurol.2009.11.019. Epub 2009 Dec 1. Exp Neurol. 2010. PMID: 19961850 Review.
-
Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.Crit Rev Immunol. 2002;22(5-6):391-424. Crit Rev Immunol. 2002. PMID: 12803318 Review.
-
Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment.Clin Neurol Neurosurg. 2006 Mar;108(3):245-9. doi: 10.1016/j.clineuro.2005.11.013. Epub 2005 Dec 27. Clin Neurol Neurosurg. 2006. PMID: 16384636 Review.
Cited by
-
Emerging roles of p53 in glial cell function in health and disease.Glia. 2012 Apr;60(4):515-25. doi: 10.1002/glia.22268. Epub 2011 Nov 21. Glia. 2012. PMID: 22105777 Free PMC article.
-
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.Cell Adh Migr. 2012 May-Jun;6(3):179-89. doi: 10.4161/cam.20341. Epub 2012 May 1. Cell Adh Migr. 2012. PMID: 22568986 Free PMC article.
-
Differentiation of C2D macrophage cells after adoptive transfer.Clin Vaccine Immunol. 2008 Feb;15(2):243-52. doi: 10.1128/CVI.00328-07. Epub 2007 Dec 19. Clin Vaccine Immunol. 2008. PMID: 18094115 Free PMC article.
-
Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.J Neuroinflammation. 2015 Jun 3;12:112. doi: 10.1186/s12974-015-0322-8. J Neuroinflammation. 2015. PMID: 26036872 Free PMC article.
-
Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases.Int J Mol Sci. 2021 Jan 27;22(3):1260. doi: 10.3390/ijms22031260. Int J Mol Sci. 2021. PMID: 33514021 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical